Drug interactions at the human placenta: what is the evidence?
Pregnant women (and their fetuses) are treated with a significant number of prescription and nonprescription medications. Interactions among those drugs may affect their efficacy and toxicity in both mother and fetus. Whereas interactions that result in altered drug concentrations in maternal plasma...
Main Authors: | Miriam eRubinchik-Stern, Sara eEyal |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00126/full |
Similar Items
-
Chronic Hypertension in Pregnancy and Placenta-Mediated Complications Regardless of Preeclampsia
by: Yair Cohen, et al.
Published: (2024-02-01) -
Editorial: Maternal-fetal interface: new insight in placenta research
by: Cilia Abad, et al.
Published: (2023-11-01) -
Collateral Damage in the Placenta during Viral Infection in Pregnancy: A Possible Mechanism for Vertical Transmission and an Adverse Pregnancy Outcome
by: Victor Javier Cruz-Holguín, et al.
Published: (2024-03-01) -
Immunomodulatory role of decidual prolactin on the human fetal membranes and placenta
by: Pilar Flores-Espinosa, et al.
Published: (2023-06-01) -
Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models
by: Nupur Chaphekar, et al.
Published: (2021-11-01)